Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
Clinical trial NCT07300488 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07300488
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-02-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.